Loading...
Cookies & Privacy. This website uses cookies to ensure you get the best experience on our website.

Press

Press Releases

 

str510k2.png

Acera Surgical Broadens Reach of Restrata® with New FDA Clearance for Soft Tissue Reinforcement

ST. LOUIS, June 25, 2025 /PRNewswire/ -- Acera Surgical, a pioneer in synthetic Electrospun materials for soft tissue repair, today announced it has received an additional U.S. Food and Drug Administration (FDA) 510(k) clearance for Restrata®, a fully synthetic, fully resorbable electrospun matrix. This new clearance broadens the clinical utility of the Restrata platform, now supporting soft tissue reinforcement applications in addition to its previously cleared indications for wound healing. This clearance applies to both Restrata Sheet and Restrata Meshed products.

 

 

 

PR_newswire1.png

Acera Surgical Announces Michael Finegan as New CEO

ST. LOUIS, May 11, 2022 /PRNewswire/ -- Acera Surgical, Inc. (Acera), a leading bioscience company developing and commercializing a portfolio of fully synthetic materials for regenerative medical applications, today announced that Michael Finegan is joining the company as CEO, effective immediately.

 

 

 

News Stories

 

tech_this_out_2.png

Dr. Burman - CBS Austin Interview

In a recent CBS Austin news segment, Dr. Sudeep Burman of ATX Robotic Surgery shared the remarkable recovery story of Texas rancher John Moore, who suffered a devastating soft tissue injury after being kicked by a cow. After debridement, Dr. Burman applied Restrata MiniMatrix, the first FDA-cleared synthetic electrospun fiber matrix for soft tissue repair. Restrata mimics the bodies own extracellular matrix, encouraging healing and helping patients like John return to what they love most.

 

 

Contact an account executive today!

Contact us today to learn more or request a product demonstration.
Revolutionizing Healing. Changing Lives.
  •  
Cerafix®, Covora®, and Restrata® are registered trademarks of Acera Surgical Inc.
  •